This talk is divided into three parts. 1) An overview of the Modeling & Simulation group at Novartis and challenges in the drug development industry. 2) An application of a mathematical model for solid tumor growth for assisting with dose selection of a cancer drug. 3) A survey of some open questions in the field of solid tumor growth modeling.